Basket Study for Oligo-metastatic Breast Cancer — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Basket Study for Oligo-metastatic Breast Cancer — Stella

Home/HER2-positive Breast Cancer/

View on ClinicalTrials.gov

Recruiting

Back to HER2-positive Breast Cancer trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

Netherlands

Antoni van Leeuwenhoek, Amsterdam

Key details

Phase

Safety & dosing

Sponsor

The Netherlands Cancer Institute

Collaborators

Daiichi Sankyo, AstraZeneca

Enrollment target

~72 participants

Started

May 2024

Primary completion

October 2027

Age range

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

18 Years and older

Last updated November 2025